• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科临床实践中的临床相关药物基因组学检测。

Clinically relevant pharmacogenomic testing in pediatric practice.

作者信息

Korbel Lindsey, George Mathew, Kitzmiller Joseph

机构信息

The Ohio State University College of Medicine, Columbus, OH, USA

St Barnabas Hospital, Bronx, NY, USA.

出版信息

Clin Pediatr (Phila). 2014 Aug;53(9):831-8. doi: 10.1177/0009922814533186. Epub 2014 May 6.

DOI:10.1177/0009922814533186
PMID:24803633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4222996/
Abstract

Clinicians and patients continue to convey interest in personalized medicine. The objective of personalized medicine is to improve healthcare by tailoring disease prevention, diagnosis, and treatment strategies for individuals based on their unique clinical history and genetic composition. This article offers an overview of pharmacogenomics, discusses caveats specific to pharmacogenomics in pediatric populations, provides evidence-based recommendations for pediatric clinicians, and offers insight regarding the future role of pharmacogenomics testing in pediatric medicine. Reviews of the current literature and thoughtful discussions are presented regarding the pharmacogenomics of antidepressants, codeine and oncologic, asthma, and immunomodulatory pharmacotherapies.

摘要

临床医生和患者对个性化医疗的兴趣持续不减。个性化医疗的目标是根据个体独特的临床病史和基因组成,量身定制疾病预防、诊断和治疗策略,从而改善医疗保健。本文概述了药物基因组学,讨论了儿科人群中药物基因组学的特殊注意事项,为儿科临床医生提供循证建议,并深入探讨了药物基因组学检测在儿科医学中的未来作用。针对抗抑郁药、可待因、肿瘤学、哮喘和免疫调节药物疗法的药物基因组学,对当前文献进行了综述并展开了深入讨论。

相似文献

1
Clinically relevant pharmacogenomic testing in pediatric practice.儿科临床实践中的临床相关药物基因组学检测。
Clin Pediatr (Phila). 2014 Aug;53(9):831-8. doi: 10.1177/0009922814533186. Epub 2014 May 6.
2
Pharmacogenomics in children.儿童药物基因组学
Methods Mol Biol. 2014;1175:687-707. doi: 10.1007/978-1-4939-0956-8_19.
3
Current perspective on pediatric pharmacogenomics.
Expert Opin Drug Metab Toxicol. 2016;12(4):363-5. doi: 10.1517/17425255.2016.1145656. Epub 2016 Feb 15.
4
Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.精神科中预先性药物基因组学的临床应用:“PREPARE”研究。
Psychiatriki. 2020 Oct-Dec;31(4):341-351. doi: 10.22365/jpsych.2020.314.341.
5
Pharmacogenomics: an Update for Child and Adolescent Psychiatry.药物基因组学:儿童和青少年精神病学的最新进展。
Curr Psychiatry Rep. 2020 May 6;22(5):26. doi: 10.1007/s11920-020-01145-4.
6
Codeine and opioid metabolism: implications and alternatives for pediatric pain management.可待因与阿片类药物代谢:对儿童疼痛管理的影响及替代方案
Curr Opin Anaesthesiol. 2017 Jun;30(3):349-356. doi: 10.1097/ACO.0000000000000455.
7
Clinical Application of Thiopurine Pharmacogenomics in Pediatrics.硫嘌呤药物基因组学在儿科的临床应用
Curr Drug Metab. 2020;21(1):53-62. doi: 10.2174/1389200221666200303113456.
8
The role of pharmacogenomics in improving the management of asthma.药物基因组学在改善哮喘管理中的作用。
J Allergy Clin Immunol. 2010 Feb;125(2):295-302; quiz 303-4. doi: 10.1016/j.jaci.2009.12.014.
9
Fifteen-minute consultation: Pharmacogenomics: a guide for busy clinicians.15 分钟咨询:药物基因组学:忙碌临床医生的指南。
Arch Dis Child Educ Pract Ed. 2020 Apr;105(2):107-110. doi: 10.1136/archdischild-2019-316971. Epub 2019 May 15.
10
Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.抗抑郁药物的药物遗传学:最新进展与临床应用——来自法国国家药物遗传学网络的建议
Therapie. 2017 Apr;72(2):311-318. doi: 10.1016/j.therap.2016.09.018. Epub 2017 Jan 30.

引用本文的文献

1
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.癌症婴儿群体中的个性化医疗:与化疗毒性和反应相关多态性的药物遗传学初步研究
Cancers (Basel). 2023 Feb 23;15(5):1424. doi: 10.3390/cancers15051424.
2
Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis.甲氨蝶呤治疗儿童克罗恩病:系统评价和荟萃分析。
Inflamm Bowel Dis. 2018 Sep 15;24(10):2135-2141. doi: 10.1093/ibd/izy078.

本文引用的文献

1
Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.CYP3A4*22 等位基因对肾移植后早期他克莫司药代动力学的影响:建立基于基因型的更新剂量指南。
Ther Drug Monit. 2013 Oct;35(5):608-16. doi: 10.1097/FTD.0b013e318296045b.
2
A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.MTHFR 多态性在预测儿童急性淋巴细胞白血病中甲氨蝶呤毒性中的系统评价和荟萃分析。
Pharmacogenomics J. 2013 Dec;13(6):498-506. doi: 10.1038/tpj.2012.44. Epub 2012 Oct 23.
3
Psychiatric pharmacogenomics in pediatric psychopharmacology.
儿童精神药理学中的精神药理学基因组学。
Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):773-88. doi: 10.1016/j.chc.2012.07.001.
4
Personalized medicine in pediatric cardiology: do little changes make a big difference?儿科心脏病学中的个性化医学:小的改变是否会产生重大影响?
Curr Opin Pediatr. 2012 Oct;24(5):584-91. doi: 10.1097/MOP.0b013e328357a4ea.
5
Pharmacogenomics in pediatric rheumatology.儿科风湿病学中的药物基因组学。
Curr Opin Rheumatol. 2012 Sep;24(5):541-7. doi: 10.1097/BOR.0b013e3283556d13.
6
Variation at GLCCI1 and FCER2: one step closer to personalized asthma treatment.
Pharmacogenomics. 2012 Feb;13(3):243-5. doi: 10.2217/pgs.11.177.
7
Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.儿童的药物遗传学与个体化治疗:免疫抑制剂、抗抑郁药、抗肿瘤药和抗炎药。
Pharmacogenomics. 2011 Jun;12(6):827-43. doi: 10.2217/pgs.11.19.
8
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery.利用表型全基因组关联研究(PheWAS)探索新的基因型-表型关系和多效性发现。
Genet Epidemiol. 2011 Jul;35(5):410-22. doi: 10.1002/gepi.20589. Epub 2011 May 18.
9
Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.甲氨蝶呤在儿童急性淋巴细胞白血病巩固期的毒性和疗效以及 MTHFR 多态性作为药物遗传学决定因素。
Cancer Chemother Pharmacol. 2011 Nov;68(5):1339-46. doi: 10.1007/s00280-011-1665-1. Epub 2011 May 18.
10
Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.药物基因组学检测:医学实践中的相关性:为什么有些患者的药物有效而有些患者的药物无效。
Cleve Clin J Med. 2011 Apr;78(4):243-57. doi: 10.3949/ccjm.78a.10145.